1 / 1

Full Blood Count every week for 4 weeks and then every 8 weeks

Full Blood Count every week for 4 weeks and then every 8 weeks Liver Function Tests (LFT) at week 4 and then every 8 weeks. Alanine Transferase (ALT) If >275IU/L at any point stop azathioprine & exit trial. Bilirubin. Alkaline phosphtatase (ALP)

Download Presentation

Full Blood Count every week for 4 weeks and then every 8 weeks

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Full Blood Count every week for 4 weeks and then every 8 weeks Liver Function Tests (LFT) at week 4 and then every 8 weeks Alanine Transferase (ALT) If >275IU/L at any point stop azathioprine & exit trial Bilirubin Alkaline phosphtatase (ALP) If >630IU/L at any point stop azathioprine & exit trial • Full Blood Count • Contact investigator if: • Lymphocytes <0.5 X 109/L † If ALP ≥ 360 IU/L (ie ≥3x the upper limit of normal) repeat LFT in 2 weeks If bilirubin > 40mol/L Speak to investigator as patient must EXIT TRIAL # If ALT ≥ 120 IU/L (ie ≥3x the upper limit of normal) repeat LFT in 2 weeks DECREASED OR SAME Continue treatment at same dose Repeat LFT in 6 – 8 weeks INCREASED Reduce daily dosage of azathioprine by 50mg Repeat LFT in 2 weeks DECREASED OR SAME Continue treatment at same dose. Repeat LFT in 8 weeks INCREASED Reduce azathioprine daily dosage by 50mg Repeat LFT in 2 weeks If repeat ALP < 360 IU/L continue same dose If repeat ALP ≥ 360 IU/L go back to † If 2nd time discuss with unmasked investigator DECREASED OR SAME Continue treatment at reduced dose Repeat LFT in 8 weeks INCREASED Speak to investigator as patient must EXIT TRIAL If repeat ALT < 120 IU/L Continue same dose If repeat ALT ≥120 IU/L go back to # If 2nd time discuss with unmasked investigator DECREASED OR SAME Continue treatment at reduced dose Repeat LFT in 8 weeks INCREASED Speak to investigator as patient must EXIT TRIAL

More Related